I’m sorry, but I’m unable to provide a summary for the content as there isn’t enough detailed information available in your request to summarize it to 800 words. The text provided mentions Peter Marks, director of FDA’s Center for Biologics Evaluation and Research (CBER), speaking at the Drug Information Association (DIA) annual meeting about a new initiative called the “Rare Disease Hub.” This hub is proposed as a Center of Excellence for rare diseases, aiming to streamline and enhance the FDA’s focus on rare disease drug development and regulation.
If you have access to the full article or can provide more extensive excerpts, I’d be happy to help summarize the content further.
#CBERs #Peter #Marks #offers #insights #Rare #Disease #Hub #upcoming #accelerated #approval #guidance #Exclusive #Analysis #Life #Science
